帕金森病相关快速眼动睡眠行为障碍的研究进展

doi:10.3969/j.issn.1003-9198.2026.02.019

Abstract

Abstract: Rapid eye movement sleep behavior disorder (RBD) is a common type of sleep disorders in Parkinson’s disease (PD) and significantly impacts patients’ quality of life. RBD has a high prevalence in the elderly population, and serves as a prodromal marker of neurodegenerative diseases. Compared with PD patients without RBD, PD-RBD patients may show more severe motor and non-motor symptoms, more severe autonomic dysfunction, faster disease progression, and worse prognosis. This article reviews recent advances in the epidemiology, clinical characteristics, pathophysiology, assessment, and management of PD-RBD. We recommend that it is necessary to establish a multidisciplinary evaluation system for PD-RBD, and strengthen the health management of RBD population, so as to identify and evaluate the disease as early as possible, delay the progression of the disease, and reduce the burden of PD.

Key words: Parkinson’s disease, rapid eye movement sleep behavior disorder, sleep disorders, neurodegenerative diseases

CLC Number:

R 742.5

HU Yue, TANG Xiaojia, XU Jun. Research progress of Parkinson’s disease-related rapid eye movement sleep behavior disorder[J]. Practical Geriatrics, 2026, 40(2): 201-205.

References

[1] SCHÄFER C, BRILL A K, WULF M A, et al. REM-sleep-behavior disorder-more than a simple parasomnia[J]. Praxis, 2025, 114(2):51-55.
[2] CARVALHO D Z, SCHÖNWALD S V, SCHUMACHER-SCHUH A F, et al. Overnight S100B in Parkinson’s disease: a glimpse into sleep-related neuroinflammation[J]. Neurosci Lett, 2015, 608: 57-63.
[3] GALBIATI A, VERGA L, GIORA E, et al. The risk of neurodegeneration in REM sleep behavior disorder:a systematic review and meta-analysis of longitudinal studies[J]. Sleep Med Rev, 2019, 43: 37-46.
[4] FERINI-STRAMBI L, FASIELLO E, SFORZA M, et al. Neuropsychological,electrophysiological, and neuroimaging biomarkers for REM behavior disorder[J]. Expert Rev Neurother, 2019, 19(11): 1069-1087.
[5] CHEN Y, XIE W Y, XIA D, et al. GBA-AAV mitigates sleep disruptions and motor deficits in mice with REM sleep behavior disorder[J]. NPJ Parkinsons Dis, 2024, 10(1): 142.
[6] SCHENCK C H, BUNDLIE S R, MAHOWALD M W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder[J]. Neurology, 1996, 46(2): 388-393.
[7] HABA-RUBIO J, FRAUSCHER B, MARQUES-VIDAL P, et al. Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population[J]. Sleep, 2018, 41(2): zsx197.
[8] RODRIGUEZ C L, JAIMCHARIYATAM N, BUDUR K. Rapid eye movement sleep behavior disorder: a review of the literature and update on current concepts[J]. Chest, 2017, 152(3): 650-662.
[9] MATAR E, MCCARTER S J, ST LOUIS E K, et al. Current concepts and controversies in the management of REM sleep behavior disorder[J]. Neurotherapeutics, 2021, 18(1): 107-123.
[10] 魏蔚, 邢佳, 王一帆, 等. 2022版《美国睡眠医学会临床实践指南: 快速眼动睡眠行为障碍的管理》解读[J]. 河北医科大学学报, 2023, 44(9): 993-997, 1042.
[11] LIU Y, NIU L, LIU X, et al. Recent progress in non-motor features of Parkinson’s disease with a focus on circadian rhythm dysregulation[J]. Neurosci Bull, 2021, 37(7): 1010-1024.
[12] SCHENCK C H, BOEVE B F, MAHOWALD M W. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series[J]. Sleep Med, 2013, 14(8): 744-748.
[13] TERZAGHI M, TOSCANO G, CASONI F, et al. Assessment of cognitive profile as a prodromal marker of the evolution of rapid eye movement sleep behavior disorder[J]. Sleep, 2019, 42(8): zsz103.
[14] VIDENOVIC A, MARLIN C, ALIBIGLOU L, et al. Increased REM sleep without atonia in Parkinson disease with freezing of gait[J]. Neurology, 2013, 81(12): 1030-1035.
[15] CHEN T Z, XU G J, ZHOU G A, et al. Postural sway in idiopathic rapid eye movement sleep behavior disorder: a potential marker of prodromal Parkinson’s disease[J]. Brain Res, 2014, 1559: 26-32.
[16] JIN H, ZHANG J R, SHEN Y, et al. Clinical significance of REM sleep behavior disorders and other non-motor symptoms of parkinsonism[J]. Neurosci Bull, 2017, 33(5): 576-584.
[17] BOEVE B F. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions[J]. Ann N Y Acad Sci, 2010, 1184: 15-54.
[18] ZHANG X, CHAI C, GHASSABAN K, et al. Assessing brain iron and volume of subcortical nuclei in idiopathic rapid eye movement sleep behavior disorder[J]. Sleep, 2021, 44(10): zsab131.
[19] RADWAN B, LIU H, CHAUDHURY D. The role of dopamine in mood disorders and the associated changes in circadian rhythms and sleep-wake cycle[J]. Brain Res, 2019, 1713: 42-51.
[20] POLITIS M, PICCINI P, PAVESE N, et al. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson’s disease: an in vivo¹¹C-raclopride PET study[J]. Exp Neurol, 2008, 214(1): 112-116.
[21] TARGA A D S, RODRIGUES L S, NOSEDA A C D, et al. Unraveling a new circuitry for sleep regulation in Parkinson’s disease[J]. Neuropharmacology, 2016, 108: 161-171.
[22] YUAN T, ZUO Z, XU J. Neuroanatomical localization of rapid eye movement sleep behavior disorder in human brain using lesion network mapping[J]. Korean J Radiol, 2023, 24(3): 247-258.
[23] SALSONE M, CERASA A, ARABIA G, et al. Reduced thalamic volume in Parkinson disease with REM sleep behavior disorder: volumetric study[J]. Parkinsonism Relat Disord, 2014, 20(9): 1004-1008.
[24] BOEVE B F, SILBER M H, SAPER C B, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease[J]. Brain, 2007, 130(Pt 11): 2770-2788.
[25] ZHANG H, GU Z, YAO C, et al. Risk factors for possible REM sleep behavior disorders:a community-based study in Beijing[J]. Neurology, 2020, 95(16): e2214-e2224.
[26] LUPPI P H, CLÉMENT O, VALENCIA GARCIA S, et al. New aspects in the pathophysiology of rapid eye movement sleep behavior disorder: the potential role of glutamate, gamma-aminobutyric acid, and glycine[J]. Sleep Med, 2013, 14(8): 714-718.
[27] BRINK-KJÆR A, CESARI M, SIXEL-DÖRING F, et al. Arousal characteristics in patients with Parkinson’s disease and isolated rapid eye movement sleep behavior disorder[J]. Sleep, 2021, 44(12): zsab167.
[28] PEREZ-LLORET S, CHEVALIER G, BORDET S, et al. The genetic basis of probable REM sleep behavior disorder in Parkinson’s disease[J]. Brain Sci, 2023, 13(8):1146.
[29] DI FOLCO C, COURONNÉ R, ARNULF I, et al. Charting disease trajectories from isolated REM sleep behavior disorder to Parkinson’s disease[J]. Mov Disord, 2024, 39(1): 64-75.
[30] GAN-OR Z, GIRARD S L, NOREAU A, et al. Parkinson’s disease genetic loci in rapid eye movement sleep behavior disorder[J]. J Mol Neurosci, 2015, 56(3): 617-622.
[31] FERNÁNDEZ-SANTIAGO R, IRANZO A, GAIG C, et al. MAPT association with REM sleep behavior disorder[J]. Neurol Genet, 2017, 3(1): e131.
[32] HOWELL M, AVIDAN A Y, FOLDVARY-SCHAEFER N, et al. Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline[J]. J Clin Sleep Med, 2023, 19(4): 759-768.
[33] CESARI M, HEIDBREDER A, ST LOUIS E K, et al. Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study Group[J]. Sleep, 2022, 45(3): zsab257.
[34] TRAUER J M, QIAN M Y, DOYLE J S, et al. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis[J]. Ann Intern Med, 2015, 163(3): 191-204.
[35] CAVALLOTTI S, STEIN H C, SAVARESE M, et al. Aggressiveness in the dreams of drug-naïve and clonazepam-treated patients with isolated REM sleep behavior disorder[J]. Sleep Med, 2022, 92: 19-23.
[36] SOBREIRA-NETO M A, STELZER F G, GITAÍ L L G, et al. REM sleep behavior disorder: update on diagnosis and management[J]. Arq Neuropsiquiatr, 2023, 81(12): 1179-1194.
[37] BLIWISE D L, TROTTI L M, GREER S A, et al. Phasic muscle activity in sleep and clinical features of Parkinson disease[J]. Ann Neurol, 2010, 68(3): 353-359.

Research progress of Parkinson’s disease-related rapid eye movement sleep behavior disorder

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	SUN Yang, GUO Ying. Research progress on drug targets for Alzheimer’s disease-related cognitive impairment [J]. Practical Geriatrics, 2026, 40(2): 116-120.
[2]	LI Jiachun, YAN Li, LIU Jiye, SUN Weimin. Research progress on drug targets for sleep disorders in the elderly [J]. Practical Geriatrics, 2026, 40(2): 121-125.
[3]	WANG Jinfeng, SONG Jiao, JIANG Yangyang, YANG Xue, LI Ying. Association between sleep quality and depressive symptoms in residents with cognitive impairment residing in nursing homes [J]. Practical Geriatrics, 2026, 40(1): 16-20.
[4]	E Yuqian, CAO Wenping, ZHAO Chunsheng, CAO Shengwu. Study on the safety of trajectory for deep brain stimulation in elderly patients [J]. Practical Geriatrics, 2025, 39(7): 727-731.
[5]	WANG Qi, WANG Zhe, WANG Yuehui. Research progress on inflammation and sleep disorders [J]. Practical Geriatrics, 2025, 39(6): 543-546.
[6]	ZHOU Xiang, XIANG Xiaoping. Effects of different-intensity phototherapy on sleep quality in elderly patients with Parkinson’s disease and insomnia [J]. Practical Geriatrics, 2025, 39(4): 401-405.
[7]	WU Ziwen, ZHANG Li. Epidemiological characteristics of chronic neurological diseases in the elderly [J]. Practical Geriatrics, 2025, 39(3): 223-227.
[8]	WANG Guanqun, WANG Xinping, YUAN Yongsheng. Research advances of artificial intelligence in the treatment of Parkinson’s disease [J]. Practical Geriatrics, 2025, 39(11): 1088-1092.
[9]	JIANG Peiming, XIAO Di, XIE Mengtong, ZHANG Yanchi, ZHANG Yupeng, YU Qiong. Application of artificial intelligence in sleep disorders of elderly [J]. Practical Geriatrics, 2025, 39(11): 1093-1097.
[10]	HU Xinyi, LI Dingkun, Aeryoubu, DUAN Jingyi, LIAO Xichu, GAO Haiying. Advances in multi-omics research on sleep disorders in elderly [J]. Practical Geriatrics, 2025, 39(10): 987-991.
[11]	XU Jie, WANG Yan, GU Xiaoping. Advances of polyphenols based on the microbial-gut-brain axis in neurodegenerative diseases [J]. Practical Geriatrics, 2025, 39(10): 1057-1061.
[12]	LI Maomao, MA Yanling, LI Jiehua. Effects of environmental exposure on sleep disorders [J]. Practical Geriatrics, 2025, 39(1): 17-21.
[13]	HUANG Mei, CHEN Hua-yu, JI Jing, ZHANG Li. Correlation of anxiety and depression with quality of life in elderly patients with Parkinson’s disease [J]. Practical Geriatrics, 2023, 37(1): 96-99.
[14]	ZHU Jun, ZHANG Li, XU Shu-lan, YAN Jun, ZHANG Juan, ZHU Yin, CHEN Shu. Study on sleep apnea hypopnea and cognitive injury in elderly patients with Parkinson’s disease [J]. Practical Geriatrics, 2022, 36(3): 240-243.
[15]	ZHOU En-zhu, XIA Li, LYU Yang, LIU Xin-tong. Study on the characteristics of sleep disorders in the elderly patients with dementia [J]. Practical Geriatrics, 2021, 35(6): 599-601.